BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33272009)

  • 1. IncRNA MAPKAPK5-AS1 promotes proliferation and migration of thyroid cancer cell lines by targeting miR-519e-5p/YWHAH.
    Zhou Y; Liu S; Luo Y; Zhang M; Jiang X; Xiong Y
    Eur J Histochem; 2020 Dec; 64(4):. PubMed ID: 33272009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAPKAPK5-AS1/miR-515-5p/CAB39 Axis Contributes to Non-small Cell Lung Cancer Cell Proliferation and Migration.
    Zhao Y; Zhou D; Yuan Y; Chen Y; Zhang K; Tan Y; Fang S
    Mol Biotechnol; 2023 Nov; 65(11):1887-1897. PubMed ID: 36867352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
    Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
    J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV16 E6 oncoprotein-induced upregulation of lncRNA GABPB1-AS1 facilitates cervical cancer progression by regulating miR-519e-5p/Notch2 axis.
    Ou R; Lv M; Liu X; Lv J; Zhao J; Zhao Y; Li X; Li W; Zhao L; Li J; Ren Y; Xu Y
    FASEB J; 2020 Oct; 34(10):13211-13223. PubMed ID: 32844486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis.
    Li C; Tan F; Pei Q; Zhou Z; Zhou Y; Zhang L; Wang D; Pei H
    Cell Prolif; 2019 Jul; 52(4):e12632. PubMed ID: 31094023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis.
    Zhuang X; Tong H; Ding Y; Wu L; Cai J; Si Y; Zhang H; Shen M
    Cell Death Dis; 2019 Aug; 10(8):620. PubMed ID: 31409775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA ARAP1-AS1 targets miR-516b-5p/PDE5A axis to facilitate the progression of thyroid cancer.
    Du Q; Huang L; Guo W
    Anticancer Drugs; 2023 Jul; 34(6):735-746. PubMed ID: 36730555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p.
    Hou S; Lin Q; Guan F; Lin C
    J Cell Biochem; 2018 Nov; 119(10):8304-8316. PubMed ID: 29893424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
    Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
    Chen Y; Gao H; Li Y
    Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA LOXL1-AS1 promotes endometrial cancer progression by sponging miR-28-5p to upregulate RAP1B expression.
    Yang X; Xing G; Liu S; Li B; He Y; Wang F
    Biomed Pharmacother; 2020 May; 125():109839. PubMed ID: 32006897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA
    Chen D; Chen J; Gao J; Zhang Y; Ma Y; Wei W; Wei Y
    Cancer Biother Radiopharm; 2020 Jun; 35(5):319-328. PubMed ID: 32412777
    [No Abstract]   [Full Text] [Related]  

  • 14. Long noncoding RNAs SET-binding factor 2-antisense RNA1 promotes cell growth through targeting miR-431-5p/CDK14 axis in human papillary thyroid cancer.
    Wen HL; Xu ZM; Wen D; Lin SY; Liang Y; Xie JP
    Kaohsiung J Med Sci; 2020 Oct; 36(10):808-816. PubMed ID: 32602632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA MCM3AP-AS1 promotes proliferation and invasion through regulating miR-211-5p/SPARC axis in papillary thyroid cancer.
    Liang M; Jia J; Chen L; Wei B; Guan Q; Ding Z; Yu J; Pang R; He G
    Endocrine; 2019 Aug; 65(2):318-326. PubMed ID: 31030335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA MAPKAPK5-AS1 promotes metastasis through regulation miR-376b-5p/ECT2 axis in hepatocellular carcinoma.
    Lv E; Sheng J; Yu C; Rao D; Huang W
    Dig Liver Dis; 2023 Jul; 55(7):945-954. PubMed ID: 36567178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F1-mediated MNX1-AS1-miR-218-5p-SEC61A1 feedback loop contributes to the progression of colon adenocarcinoma.
    Ye Y; Gu B; Wang Y; Shen S; Huang W
    J Cell Biochem; 2019 Apr; 120(4):6145-6153. PubMed ID: 30362161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA AFAP-AS1 promotes anaplastic thyroid cancer progression by sponging miR-155-5p through ETS1/ERK pathway.
    Ning M; Qin S; Tian J; Wang Y; Liu Q
    Bioengineered; 2021 Dec; 12(1):1543-1554. PubMed ID: 33999777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
    Li GH; Yu JH; Yang B; Gong FC; Zhang KW
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA TMPO-AS1 promotes lung adenocarcinoma progression and is negatively regulated by miR-383-5p.
    Mu X; Wu H; Liu J; Hu X; Wu H; Chen L; Liu W; Luo S; Zhao Y
    Biomed Pharmacother; 2020 May; 125():109989. PubMed ID: 32062549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.